Cosmo Pharmaceuticals N.V. (FRA:C43)

Germany flag Germany · Delayed Price · Currency is EUR
109.00
+2.00 (1.87%)
At close: Dec 19, 2025
70.31%
Market Cap1.72B
Revenue (ttm)182.27M
Net Income (ttm)59.99M
Shares Outn/a
EPS (ttm)3.67
PE Ratio28.67
Forward PE368.90
Dividend2.05 (1.95%)
Ex-Dividend DateJun 4, 2025
Volume120
Average Volume683
Open108.00
Previous Close107.00
Day's Range108.00 - 109.00
52-Week Range47.80 - 116.00
Betan/a
RSI75.00
Earnings DateMar 6, 2026

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 322
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C43
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.